Roivant Sciences Ltd (ROIV)

Feb 27, 2026

Fox Run Management L.L.C. Invests $877,000 in Roivant Sciences Ltd. $ROIV - MarketBeat

Feb 27, 2026

Feb 26, 2026

Liquidity Mapping Around (ROIV) Price Events - Stock Traders Daily

Feb 26, 2026

Feb 25, 2026

IPO Launch: Can Roivant Sciences Ltd outperform under higher oil pricesMarket Performance Report & Weekly Top Performers Watchlists - baoquankhu1.vn

Feb 25, 2026

Feb 25, 2026

Analyst Downgrade: What is the dividend yield of Roivant Sciences LtdJuly 2025 Summary & Detailed Earnings Play Alerts - baoquankhu1.vn

Feb 25, 2026

Feb 25, 2026

Vanguard Group Inc. Has $587.12 Million Stake in Roivant Sciences Ltd. $ROIV - MarketBeat

Feb 25, 2026

Feb 25, 2026

Roivant Sciences stock hits all-time high at 27.95 USD - Investing.com India

Feb 25, 2026

Feb 25, 2026

Roivant Sciences (ROIV) Price Target Increased by 18.98% to 32.44 - Nasdaq

Feb 25, 2026

Feb 24, 2026

Support Test: Should I hold or sell Roivant Sciences Ltd nowMarket Performance Summary & Free Daily Entry Point Trade Alerts - baoquankhu1.vn

Feb 24, 2026

Feb 24, 2026

Roivant Sciences (NASDAQ:ROIV) Sets New 52-Week HighShould You Buy? - MarketBeat

Feb 24, 2026

Feb 24, 2026

Roivant Sciences stock hits all-time high at 27.95 USD By Investing.com - Investing.com South Africa

Feb 24, 2026

Feb 23, 2026

Roivant Sciences (NASDAQ:ROIV) Insider Sells $27,492,361.50 in Stock - MarketBeat

Feb 23, 2026

Feb 23, 2026

Roivant Sciences (NASDAQ:ROIV) Insider Sells $16,159,098.90 in Stock - MarketBeat

Feb 23, 2026

Feb 23, 2026

Insider Selling: Roivant Sciences (NASDAQ:ROIV) Insider Sells 1,400,000 Shares of Stock - MarketBeat

Feb 23, 2026

Feb 23, 2026

Aug Chart Watch: What is the dividend yield of Roivant Sciences LtdTreasury Yields & Reliable Trade Execution Plans - baoquankhu1.vn

Feb 23, 2026

Feb 23, 2026

Roivant Sciences Ltd. (ROIV) Investor Outlook: Analyzing Its 16.86% Potential Upside - DirectorsTalk Interviews

Feb 23, 2026

Feb 20, 2026

Published on: 2026-02-21 23:52:14 - baoquankhu1.vn

Feb 20, 2026

Feb 19, 2026

CenterBook Partners LP Grows Stake in Roivant Sciences Ltd. $ROIV - MarketBeat

Feb 19, 2026

Feb 18, 2026

Eric Venker Sells 200,000 Shares of Roivant Sciences (NASDAQ:ROIV) Stock - MarketBeat

Feb 18, 2026

Feb 18, 2026

Risk Off: Can Veracyte Inc ride the EV waveQuarterly Profit Summary & Weekly Return Optimization Alerts - baoquankhu1.vn

Feb 18, 2026

Feb 17, 2026

Why Roivant Sciences Ltd. (87S) stock appeals to dividend investorsTrade Ideas & Long-Term Growth Plans - mfd.ru

Feb 17, 2026

Feb 15, 2026

Why (ROIV) Price Action Is Critical for Tactical Trading - Stock Traders Daily

Feb 15, 2026

Feb 15, 2026

Roivant Sciences Advances PHocus Trial Milestone As Shares Trade Below Targets - simplywall.st

Feb 15, 2026

Feb 15, 2026

Roivant Sciences PHocus Trial Milestone Highlights Pipeline Progress And Valuation Gap - Yahoo Finance

Feb 15, 2026

Feb 15, 2026

Momentum Shift: Is Roivant Sciences Ltd backed by strong institutional buying2025 Growth vs Value & Short-Term Trading Alerts - baoquankhu1.vn

Feb 15, 2026

Feb 14, 2026

Is Roivant Sciences Ltd. stock a contrarian buyJuly 2025 Trade Ideas & Weekly High Return Forecasts - mfd.ru

Feb 14, 2026

Feb 14, 2026

Roivant Sciences Advances PH Programs As Investors Weigh Pipeline Milestones - simplywall.st

Feb 14, 2026

Feb 14, 2026

Citi raises Roivant Sciences (ROIV) PT to $35 following positive phase 2 brepocitinib data - MSN

Feb 14, 2026

Feb 14, 2026

Citi Raises Roivant Sciences (ROIV) PT to $35 Following Positive Phase 2 Brepocitinib Data - Insider Monkey

Feb 14, 2026

Feb 13, 2026

Insider Selling: Roivant Sciences (NASDAQ:ROIV) Director Sells 375,784 Shares of Stock - MarketBeat

Feb 13, 2026

Feb 13, 2026

Roivant Sciences (NASDAQ:ROIV) Director Daniel Allen Gold Sells 425,000 Shares - MarketBeat

Feb 13, 2026

Feb 13, 2026

Healthcare REIT Posts 16.4% NOI Growth as Shares Soar 93%: Why This Fund's New Stake Stands Out - The Motley Fool

Feb 13, 2026

Feb 13, 2026

HC Wainwright Analysts Increase Earnings Estimates for ROIV - MarketBeat

Feb 13, 2026

Feb 12, 2026

Is Roivant Sciences Ltd. stock undervalued right now2025 Short Interest & AI Based Buy and Sell Signals - mfd.ru

Feb 12, 2026

Feb 12, 2026

Can Roivant Sciences Ltd. lead its sector in growthLayoff News & Detailed Earnings Play Alerts - mfd.ru

Feb 12, 2026

Feb 11, 2026

Roivant Sciences (NASDAQ:ROIV) Insider Sells $8,985,003.27 in Stock - MarketBeat

Feb 11, 2026

Feb 11, 2026

Impax Asset Management Group plc Sells 200,000 Shares of Roivant Sciences Ltd. $ROIV - MarketBeat

Feb 11, 2026

Feb 10, 2026

Roivant Sciences stock price target raised to $38 from $36 at Goldman Sachs - Investing.com Australia

Feb 10, 2026

Feb 10, 2026

Candriam S.C.A. Increases Position in Roivant Sciences Ltd. $ROIV - MarketBeat

Feb 10, 2026

Feb 10, 2026

Roivant Sciences stock price target raised to $33 from $26 at H.C. Wainwright - Investing.com Australia

Feb 10, 2026

Feb 10, 2026

TD Cowen Remains Bullish on Roivant Sciences Ltd. (ROIV)Here's Why - Finviz

Feb 10, 2026

Feb 10, 2026

Citi raises Roivant Sciences stock price target to $35 from $26 - Investing.com Australia

Feb 10, 2026

Feb 10, 2026

Roivant Sciences stock price target raised to $38 from $36 at Goldman Sachs By Investing.com - Investing.com South Africa

Feb 10, 2026

Feb 10, 2026

TD Cowen Remains Bullish on Roivant Sciences Ltd. (ROIV) – Here’s Why - Insider Monkey

Feb 10, 2026

Feb 10, 2026

Roivant Sciences stock hits all-time high at 26.35 USD - Investing.com Australia

Feb 10, 2026

Feb 10, 2026

Roivant Sciences stock hits all-time high at 26.35 USD By Investing.com - Investing.com Canada

Feb 10, 2026

Feb 09, 2026

Roivant Sciences Earnings Call Highlights Brepocitinib Surge - TipRanks

Feb 09, 2026

Feb 09, 2026

Deep Dive Into Roivant Sciences Stock: Analyst Perspectives (4 Ratings) - Benzinga

Feb 09, 2026

Feb 09, 2026

Roivant signals multiple pivotal trial readouts and accelerates brepocitinib phase III launch in 2026 - MSN

Feb 09, 2026